Informazioni sul prodotto
Ledipasvir D-tartrate is a synthetic, broad-spectrum antiviral agent that is used to treat hepatitis C virus (HCV) infection. It inhibits the HCV NS5A protein, which is needed for viral replication and assembly. Ledipasvir D-tartrate was discovered by scientists at Gilead Sciences. The drug was approved for use in combination with sofosbuvir in 2017 as an oral treatment for chronic HCV infection.
Ledipasvir D-tartrate binds to the NS5A protein and blocks its ability to function, thereby inhibiting viral replication. Ledipasvir D-tartrate also prevents the production of new viruses by blocking the activity of other proteins needed for viral assembly and release from infected cells.
It is effective against a wide variety of microorganisms, including bacteria, fungi, and parasites. It has been shown to be active against methicillin-resistant Staphylococ
Proprietà chimiche
Richiesta tecnica su: 3D-FL180961 Ledipasvir D-tartrate
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
